Open AccessStudy of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease
Author(s) -
Rachel Orme,
William A. Parker,
Mark R. Thomas,
Heather M Judge,
Kathleen Baster,
Wael Sumaya,
K. Morgan,
Hannah McMellon,
J. David Richardson,
Ever Grech,
Nigel Wheeldon,
Ian Hall,
Javaid Iqbal,
David Barmby,
Julian Gunn,
Robert F. Storey
Publication year - 2018
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.118.034790
Subject(s) - medicine , ticagrelor , clopidogrel , percutaneous coronary intervention , coronary artery disease , loading dose , aspirin , cardiology , p2y12 , ticlopidine , anesthesia , population , myocardial infarction , environmental health
Ticagrelor has superior efficacy to clopidogrel in the management of acute coronary syndromes but has not been assessed in patients undergoing percutaneous coronary intervention for stable coronary artery disease. We compared the pharmacodynamic effects of ticagrelor and clopidogrel in this stable population.